Researchers develop light-activated Parkinson’s drug

News

Author: Simge Eva DoganPublished: 18 July 2018

Prep: Cook: Serves:

A new light-activated drug for treating Parkinson’s has been developed by a research team led by the University of Barcelona, Spain.

The drug – named MRS7145 – is placed within a brain implant and then activated by shining a light on it.

The effect of the newly developed drug was tested on live mice to see if it could improve their motor function. The results – published in ‘Journal of Controlled Release’ – showed that MRS7145 reduced tremors and seizures and improved the mice’s ability to walk.

Professor Francisco Ciruela, researcher at the Faculty of Medicine and Health Sciences of the University of Barcelona, Spain, said he envisaged the drug being administered by smart phones, with “the doctor (controlling) in a precise manner the release of the most efficient dose of the active drug in the place of action”.

For more information on Parkinson’s research please visit the EPDA website.

Last Month

Next Month

Go Back

Share this story

Comments

Resources & Tools

What’s going on in Washington DC, and what does it mean for people with Parkinson’s?

GyroGlove: call for volunteers to test award-winning, tremor-reducing wearable

How will ‘Brexit’ affect Parkinson’s research in the UK?

What next for Parkinson’s research funding after the UK leaves the EU?

Plant-based compounds could treat chronic pain in Parkinson’s, study finds

A six-year study has found that chronic pain in people with Parkinson’s is linked to a gene involved with how the brain responds to cannabis compounds. The investigation examined why some people with the condition experience persistent pain – and the impact it has on their work, daily life and social relationships. Conducted by researchers at Manchester’s Salford Royal Foundation Trust, UK, and funded by Parkinson’s UK, it is the largest study to investigate chronic pain in people with Parkinson’s. Dr Monty Silverdale, consultant neurologist at Greater Manchester Centre, said: “This study is significant because it shows the important role of genetics in chronic pain in Parkinson’s. “Our findings suggest that cannabis-based compounds may be worth investigating as a treatment for pain in Parkinson’s.”

Could playing table tennis help reduce Parkinson’s symptoms?

Researchers at Fukuoka University, Japan, have found that playing table tennis may help alleviate motor symptoms in Parkinson’s. As part of the study, 12 people with Parkinson’s with an average age of 73 played a five-hour session of table tennis every week for a period of six months. The sessions were developed specifically for people with the condition by experienced table tennis players from the university’s department of sports science. The participants were evaluated after three months and at the end of the study. At both evaluations, participants had reduced symptoms – showing improvement in speech, handwriting, walking and hand tremors. Two participants reported side-effects of backache and falling. Study author Ken-ichi Inoue, MD, of Fukuoka University said: “While this study is small, the results are encouraging because they show ping pong, a relatively inexpensive form of therapy, may improve some symptoms of Parkinson’s disease. A much larger study is…

‘Dopamine-boosting’ BT13 molecule could be used to slow Parkinson’s

Researchers have discovered that a molecule called BT13 could have potential to treat Parkinson’s. The study, conducted by scientists from the University of Helsinki, Finland, found that mice injected with the BT13 molecule had an increase in dopamine levels in the brain. Their findings also suggested that the molecule could lead to a new drug treatment to protect the brain cells that produce dopamine. Dopamine helps coordinate movement, but people with Parkinson’s have normally lost between 70 and 80% of the brain cells that produce the neurotransmitter when they are diagnosed with the condition. Professor David Dexter, Deputy Director of Research at Parkinson’s UK – which co-funded the study – said: “People with Parkinson’s desperately need a new treatment that can stop the condition in its tracks, instead of just masking the symptoms. “More research is needed to turn BT13 into a treatment to be tested in clinical trials, to…

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Comments
This field is for validation purposes and should be left unchanged.

Researchers develop light-activated Parkinson’s drug

News

Author: Simge Eva DoganPublished: 18 July 2018

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Resources & Tools

What’s going on in Washington DC, and what does it mean for people with Parkinson’s?

Advances

GyroGlove: call for volunteers to test award-winning, tremor-reducing wearable

Perspectives

How will ‘Brexit’ affect Parkinson’s research in the UK?

Plant-based compounds could treat chronic pain in Parkinson’s, study finds

Could playing table tennis help reduce Parkinson’s symptoms?

‘Dopamine-boosting’ BT13 molecule could be used to slow Parkinson’s

{title}

Subscribe

Researchers develop light-activated Parkinson’s drug

News

Author: Simge Eva DoganPublished: 18 July 2018

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Related articles

Resources & Tools

What’s going on in Washington DC, and what does it mean for people with Parkinson’s?

Advances

GyroGlove: call for volunteers to test award-winning, tremor-reducing wearable

Perspectives

How will ‘Brexit’ affect Parkinson’s research in the UK?

Plant-based compounds could treat chronic pain in Parkinson’s, study finds

Could playing table tennis help reduce Parkinson’s symptoms?

‘Dopamine-boosting’ BT13 molecule could be used to slow Parkinson’s

{title}

Subscribe

Sign in